Search research articles
Contact Us
Filters
Showing results (101-110 of 225) with videos related to
Page
of 23
Sort By:
British Journal of Haematology
|
January 3, 2013
Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era
Philippe Armand, Sarah Welch, Haesook T Kim, et al.
Genome Biology
|
June 3, 2026
Publisher Correction: Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemia
Anja C Rathgeber, Stacey M Fernandes, Adi Nagler, et al.
Cold Spring Harbor Molecular Case Studies
|
June 2, 2021
Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis
Panieh Terraf, Lynette M Sholl, Matthew S Davids, et al.
BMC Cancer
|
March 18, 2017
Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States
Chadi Nabhan, Anthony Mato, Christopher R Flowers, et al.
Advances in Hematology
|
December 2, 2025
Clinical Outcomes in Patients With CLL Treated With BTKi at a Large US Cancer Center
Kevin H Lin, Lynn Huynh, Xiaoqin Yang, et al.
Cancers
|
February 27, 2026
Efficacy of Pirtobrutinib Monotherapy in Treatment-Naïve Chronic Lymphocytic Leukemia: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Toby A Eyre, Lisa M Hess, Ehsan Masoudi, et al.
Cancer Research
|
June 13, 2012
BCL2 suppresses PARP1 function and nonapoptotic cell death
Chaitali Dutta, Tovah Day, Nadja Kopp, et al.
Haematologica
|
July 1, 2021
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisib
Veronika Sandova, Gabriela Mladonicka Pavlasova, Vaclav Seda, et al.
Blood
|
January 7, 2018
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy
Steven Coutre, Michael Choi, Richard R Furman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
Long-term Follow-up of Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study
Matthew S Davids, Andrew W Roberts, Vaishalee P Kenkre, et al.
Page
of 23
Search research articles
Search
Showing results (101-110 of 225) with videos related to
Sort By:
Page
of 23
British Journal of Haematology
|
January 3, 2013
Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era
Philippe Armand, Sarah Welch, Haesook T Kim, et al.
Genome Biology
|
June 3, 2026
Publisher Correction: Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemia
Anja C Rathgeber, Stacey M Fernandes, Adi Nagler, et al.
Cold Spring Harbor Molecular Case Studies
|
June 2, 2021
Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis
Panieh Terraf, Lynette M Sholl, Matthew S Davids, et al.
BMC Cancer
|
March 18, 2017
Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States
Chadi Nabhan, Anthony Mato, Christopher R Flowers, et al.
Advances in Hematology
|
December 2, 2025
Clinical Outcomes in Patients With CLL Treated With BTKi at a Large US Cancer Center
Kevin H Lin, Lynn Huynh, Xiaoqin Yang, et al.
Cancers
|
February 27, 2026
Efficacy of Pirtobrutinib Monotherapy in Treatment-Naïve Chronic Lymphocytic Leukemia: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Toby A Eyre, Lisa M Hess, Ehsan Masoudi, et al.
Cancer Research
|
June 13, 2012
BCL2 suppresses PARP1 function and nonapoptotic cell death
Chaitali Dutta, Tovah Day, Nadja Kopp, et al.
Haematologica
|
July 1, 2021
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisib
Veronika Sandova, Gabriela Mladonicka Pavlasova, Vaclav Seda, et al.
Blood
|
January 7, 2018
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy
Steven Coutre, Michael Choi, Richard R Furman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
Long-term Follow-up of Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study
Matthew S Davids, Andrew W Roberts, Vaishalee P Kenkre, et al.
Page
of 23